News Feed

A new study suggests that a blood protein called GDF15 could help identify people at risk of dementia years before symptoms appear. Researchers followed more than half a million individuals for up to 25 years and found that higher GDF15 levels before age 55 were linked to a significantly greater risk of developing dementia later in life, particularly vascular dementia. Elevated GDF15 was also associated with brain shrinkage and damage to small blood vessels, even in people with normal memory and thinking abilities. While more research is needed, this simple blood test could one day help detect dementia risk early and support timely prevention strategies.

A new study suggests that accelerated biological aging may help explain the increasing rates of cancer in adults under 50. Researchers found that younger generations showed a greater gap between their biological and chronological ages compared to older generations. People with the highest biological age scores had about a 15% greater risk of developing early-onset solid cancers, particularly lung, gastrointestinal, and uterine cancers. While the findings do not prove that faster aging causes cancer, they offer important clues about why cancer diagnoses are rising in younger adults. Scientists stress that larger studies are needed to confirm these results and better understand the underlying mechanisms.

Researchers have developed a promising nanosensor that may enable earlier and more accurate diagnosis of autism spectrum disorder (ASD). The device measures nitric oxide (NO) levels in patient-derived stem cells, successfully distinguishing ASD from intellectual disability (ID), even when both conditions share the same genetic mutation. Unlike traditional blood-based tests, this approach bypasses the blood-brain barrier and does not require stem cells to be converted into neurons, making the process simpler. Scientists believe this technology could eventually allow autism to be detected within the first few months of life using somatic cells. However, larger studies are needed before it can be introduced into clinical practice.

A new study suggests that routine eye exams could play an important role in detecting hidden high blood pressure in people with diabetes. Researchers found that only 8% of diabetic patients had normal blood pressure, while nearly half had stage 2 hypertension and over 10% had blood pressure levels high enough to qualify as a medical emergency. Surprisingly, many patients believed their blood pressure was well controlled when it was not. Since 93% of participants supported blood pressure screening during eye appointments, researchers recommend making these checks a routine part of ophthalmology visits to identify hypertension early and reduce the risk of heart attacks, strokes, and vision loss.

A recent clinical trial found that a blend of dietary fibers from wheat, citrus, and oats significantly improved symptoms of chronic functional constipation. Participants taking the fiber supplement experienced more frequent bowel movements, softer stools, and reduced bloating, abdominal heaviness, and discomfort compared to those receiving a placebo. Improvements became noticeable within two weeks, and the supplement was well tolerated with no reported side effects or need for rescue laxatives. Researchers believe the combination of soluble and insoluble fibers works through complementary mechanisms to support healthy bowel function and gut microbes. While the findings are encouraging, larger and longer-term studies are needed to confirm these benefits.

A new study suggests that when cancer treatment is given may be just as important as what treatment is used. Researchers found that patients with advanced non-small cell lung cancer who received immunochemotherapy before 3:00 pm had longer overall and progression-free survival than those treated later in the day. The findings support the growing field of cancer chronotherapy, which aligns treatment with the body's natural circadian rhythm to improve effectiveness and reduce side effects. Although the results are promising, experts emphasize that larger clinical trials are needed before treatment timing becomes a standard part of personalized cancer care.

Scientists have identified a new factor that may explain why multiple sclerosis (MS) progresses more rapidly in some people than others. Researchers found large numbers of “foamy” immune cells in the brains of patients with severe MS. These cells become overloaded with fat droplets after engulfing damaged myelin, the protective coating around nerve fibers. Instead of supporting repair, the fat-filled cells appear to trigger chronic inflammation and further nerve damage, potentially accelerating disease progression. The findings offer new insight into MS biology and highlight these immune cells as a promising target for future therapies aimed at slowing or preventing worsening of the disease.

Scientists have discovered a promising new strategy to fight pancreatic cancer using experimental compounds known as PCAIs. In laboratory studies, a leading PCAI compound blocked more than 90% of cancer cell migration, suggesting it could help prevent tumor spread. Instead of shutting down cancer-promoting signals, the treatment took an unusual approach by hyperactivating key cellular pathways, pushing cancer cells beyond their limits and triggering self-destruction. This innovative mechanism could offer a new way to target one of the most aggressive and treatment-resistant cancers. While the results are highly encouraging, further preclinical and clinical studies are needed to confirm the therapy's safety and effectiveness.

Creatine, a popular supplement known for improving muscle strength and athletic performance, may also have potential as a treatment for depression. A recent review analyzed five randomized clinical trials involving 238 participants to evaluate its effects on mental health. While two studies involving women with major depressive disorder found that creatine enhanced the benefits of standard antidepressant treatment, three other trials showed no significant improvement. Researchers believe creatine may support brain function by increasing cellular energy, but the current evidence remains mixed. Larger, well-designed clinical trials are needed before creatine can be recommended as a routine treatment for depression.

Researchers have identified a potential mechanism that may explain how Alzheimer’s disease spreads through the brain. The study suggests that a common brain protein may transport toxic Tau proteins from damaged neurons to healthy ones, allowing the disease to progressively affect new brain regions. By blocking these harmful protein-containing packages before they enter healthy cells, scientists believe it may be possible to slow or even halt the progression of Alzheimer's. While the findings are still in the research stage and require further validation, they offer a promising new target for developing future treatments aimed at delaying disease progression rather than simply managing symptoms.